Pulmonary function tests: An update

Consultant

Volumn 43, Issue 7, 2003, Pages 813-820

  Bahhady, Imad J ^a   Unterborn, John ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; METHACHOLINE;

ALLERGIC PNEUMONITIS; ARTIFICIAL VENTILATION; ASTHMA; BRONCHIOLITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONNECTIVE TISSUE DISEASE; DISABILITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG INDUCED DISEASE; EMPHYSEMA; EVIDENCE BASED MEDICINE; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HISTIOCYTOSIS X; HUMAN; LUNG ALVEOLUS PROTEINOSIS; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG RESECTION; LUNG SARCOIDOSIS; LUNG TOXICITY; LUNG TRANSPLANTATION; LUNG VOLUME; LYMPHANGIOLEIOMYOMATOSIS; NEUROMUSCULAR DISEASE; PNEUMONIA; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SCREENING TEST; SURVIVAL RATE;

EID: 0037678438     PISSN: 00107069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Zielinski J, Bednarek M, for the Know the Age of Your Lung Study Group. Early detection of COPD in a high-risk population using spirometric screening. Chest. 2001;119:731-736.
2. 1. The Lung Health Study. JAMA. 1994;272:1497-1505.
3. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med. 2001;164:372-377.
4. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest. 2000;117:1146-1161.
5. American College of Physicians. Preoperative pulmonary function testing. Ann Intern Med. 1990;112:793-794.
6. Powell CA, Caplan CE. Pulmonary function tests in preoperative pulmonary evaluation. Clin Chest Med. 2001;22:703-714, viii.
7. American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Practice advisory for preanesthesia evaluation: a report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Anesthesiology. 2002;96:485-496.
8. Waxman AB. Pulmonary function test abnormalities in pulmonary vascular disease and chronic heart failure. Clin Chest Med. 2001;22:751-758.
9. Thomas PS, Cowen ER, Hulands G, Milledge JS. Respiratory function in the morbidly obese before and after weight loss. Thorax. 1989;44:382-386.
10. Crapo RO. Pulmonary-function testing. N Engl J Med. 1994;331:25-30.
11. National Heart, Lung, and Blood Institute. New NHLBI guidelines for the diagnosis and management of asthma. Lippincott Health Promot Lett. 1997;2:1, 8-9.
12. Hunter CJ, Brightling CE, Woltmann G, et al. A comparison of the validity of different diagnostic tests in adults with asthma. Chest. 2002;121:1051-1057.
13. Goldstein MF, Pacana SM, Dvorin DJ, Dunsky EH. Retrospective analyses of methacholine inhalation challenges. Chest. 1994;105:1082-1088.
14. Alhamad EH, Lynch JP 3rd, Martinez FJ. Pulmonary function tests in interstitial lung disease: what role do they have? Clin Chest Med. 2001;22:715-750, ix.
15. Epler GR, McLoud TC, Gaensler EA, et al. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med. 1978;298:934-939.
16. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987;107:216-223.
17. Cressy DS, DeBoisblanc BP. Diagnosis and management of asthma: a summary of the National Asthma Education and Prevention Program guidelines. National Institutes of Health. J La State Med Soc. 1998;150:611-617.
18. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339:1194-1200.
19. Cibella F, Cuttitta G, Bellia V, et al. Lung function decline in bronchial asthma. Chest. 2002;122:1944-1948.
20. Turner MO, Noertjojo K, Vedal S, et al. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med. 1998;157:1804-1809.
21. Mitchell I, Tough SC, Semple LK, et al. Near-fatal asthma: a population-based study of risk factors. Chest. 2002;121:1407-1413.
22. Lee P, Abisheganaden J, Chee CB, Wang YT. A new asthma severity index: a predictor of near-fatal asthma? Eur Respir J. 2001;18:272-278.
23. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am Rev Respir Dis. 1979;119:895-902.
24. Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med. 1990;11:555-569.
25. Nishimura K, Izumi T, Tsukino M. Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434-1440.
26. Crapo RO. Carbon monoxide diffusing capacity (transfer factor). Semin Respir Crit Care Med. 1998;19:335-347.
27. Morrison NJ, Abboud RT, Ramadan F, et al. Comparison of carbon monoxide diffusing capacity and pressure-volume curves in detecting emphysema. Am Rev Respir Dis. 1989;139:1179-1187.
28. Gould GA, Redpath AT, Ryan M, et al. Lung CT density correlates with measurements of airflow limitation and the diffusing capacity. Eur Respir J. 1991;4:141-146.
29. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152(5 pt 2):S77-S121.
30. Kessler R, Faller M, Fourgaut G, et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:158-164.
31. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-117.
32. Doherty MJ, Pearson MG, O'Grady EA, et al. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax. 1997;52:998-1002.
33. Hanson D, Winterbauer RH, Kirtland SH, Wu R. Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. Chest. 1995;108:305-310.
34. 2 predict survival? Chest. 2002;122:779-784.
35. Kadikar A, Maurer J, Kesten S. The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant 1997;16:313-319.
36. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115:343-349.
37. Cahalin LP, Mathier MA, Semigran MJ, et al. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest. 1996;110:325-332.
38. Rhodes J, Barst RJ, Garofano RP, et al. Hemodynamic correlates of exercise function in patients with primary pulmonary hypertension. J Am Coll Cardiol. 1991;18:1738-1744.
39. De Nino LA, Lawrence VA, Averyt EC, et al. Preoperative spirometry and laparotomy: blowing away dollars. Chest. 1997;111:1536-1541.
40. Chan B, Anderson G, Dales RE. Spirometry utilization in Ontario: practice patterns and policy implications. CMAJ. 1997;156:169-176.